|search externally:||Google Scholar, Springer, CiteSeer, Microsoft Academic Search, Scirus , DBlife|
Dr. Willard was appointed the first Director of the Institute for Genome Sciences & Policy at Duke University and Vice Chancellor for Genome Sciences at Duke University Medical Center in December, 2002. He is also the Nanaline H. Duke Professor of Genome Sciences, with appointments in the Department of Molecular Genetics and Microbiology and the Department of Biology.
Prior to coming to Duke University, he held faculty positions at the University of Toronto, Stanford University and Case Western Reserve University, and was Chairman of the Department of Genetics at Case Western Reserve University from 1992 to 2001. He was Director and President of the Research Institute of University Hospitals of Cleveland from 1999 until moving to Duke. He has served in elected leadership positions for the American Society of Human Genetics (President in 2001), the Association of Professors of Human/Medical Genetics, and the Human Genome Organization. He is a former member and chair of the Mental Retardation and Developmental Disabilities Research Committee, former chair of the Mammalian Genetics study section at the National Institutes of Health and a former member of the Advisory Committee on Genetics, Health and Society for the Secretary of the Department of Health and Human Services of the U.S. Government.
Dr. Willard also serves on review boards for the Howard Hughes Medical Institute and the March of Dimes Birth Defects Foundation, as well as on Scientific Advisory Boards for several biotechnology companies and independent research institutes. He has served on the editorial boards of numerous scientific journals and is co-founder and Executive Editor of Human Molecular Genetics. Dr. Willard has been the author or co-author of over 300 scientific publications. He is also co-author of Genetics in Medicine, a widely used textbook, now in its sixth edition.
Dr. Willard's research interests include genome sciences and their broad implications for medicine and society, human chromosome structure and function, X chromosome inactivation and epigenetic mechanisms of gene silencing, as well as development of human artificial chromosomes for studies of gene transfer and functional genomics.
Academic Perspectives/Panel Discussion
as author at MIT Industrial Liaison Program,
together with: Douglas Lauffenburger (moderator), James Cassatt, Leroy Hood, H. Steven Wiley, Marc W. Kirschner, George Poste, Matthew P. Scott, Peter Sorger, David Botstein,